Skip to main content
TipRanks
Go Ultimate75% OFF

Sunder Biomedical Tech. Co., Ltd. (4115) Cash flow

Sunder Biomedical Tech. Co., Ltd. Cash Flow

TW:4115's free cash flow for Q2 2026 was NT$-26.12M. For the 2026 fiscal year, TW:4115's free cash flow was decreased by NT$-48.88M and operating cash flow was NT$22.76M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 70.59MNT$ 108.13MNT$ 47.41MNT$ 104.42MNT$ 177.86M
NT$ -90.15MNT$ 9.25MNT$ -101.21MNT$ -4.60MNT$ -70.98M
NT$ -10.44MNT$ -97.41MNT$ 30.52MNT$ -94.65MNT$ -94.60M
NT$ 99.23MNT$ 130.44MNT$ 108.05MNT$ 133.62MNT$ 127.64M
NT$ -7.85MNT$ 9.98MNT$ -13.83MNT$ 30.58MNT$ 83.13M

Currency in TWD

Sunder Biomedical Tech. Co., Ltd. Cash Flow

-200M-100M0100M200M2019202020212022202320242025OperatingInvestingFinancing